Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 348
Gene Symbol: APOE
APOE
0.400 GeneticVariation disease BEFREE Apolipoprotein E Gene Polymorphism and Subclinical Carotid Atherosclerosis: The Northern Manhattan Study. 29103864 2018
Entrez Id: 348
Gene Symbol: APOE
APOE
0.400 GeneticVariation disease BEFREE Bile acid synthesis precursors in subjects with genetic hypercholesterolemia negative for LDLR/APOB/PCSK9/APOE mutations. Association with lipids and carotid atherosclerosis. 27769814 2017
Entrez Id: 348
Gene Symbol: APOE
APOE
0.400 GeneticVariation disease BEFREE APOE polymorphism and carotid atherosclerosis in Korean population: the Dong-gu Study and the Namwon Study. 24401234 2014
Entrez Id: 348
Gene Symbol: APOE
APOE
0.400 GeneticVariation disease BEFREE The ApoE4 genotype may be a risk factor for carotid atherosclerosis, but is not correlated with bone mineral density (BMD) in the lumbar spine in elderly Han males. 22178106 2012
Entrez Id: 348
Gene Symbol: APOE
APOE
0.400 GeneticVariation disease BEFREE In our Thai population, the ε4 allele in the APOE gene contributes to the genetic susceptibility of extracranial internal carotid atherosclerosis. 21296594 2012
Entrez Id: 348
Gene Symbol: APOE
APOE
0.400 GeneticVariation disease BEFREE Nuclear magnetic resonance lipoprotein subclasses and the APOE genotype influence carotid atherosclerosis in patients with systemic lupus erythematosus. 20682673 2010
Entrez Id: 348
Gene Symbol: APOE
APOE
0.400 GeneticVariation disease BEFREE Additionally, study subjects with two risk genotypes of APOE and MCP-1 and either had ingested well water contained arsenic level >10 microg/L or had arsenic exposure >0.22 mg/L-year would have strikingly highest risk of 10.3-fold and 15.7-fold, respectively, for the development carotid atherosclerosis, showing significant joint effect of arsenic exposure and risk genotypes of APOE and MCP-1. 18022660 2008
Entrez Id: 348
Gene Symbol: APOE
APOE
0.400 Biomarker disease CTD_human Additionally, study subjects with two risk genotypes of APOE and MCP-1 and either had ingested well water contained arsenic level >10 microg/L or had arsenic exposure >0.22 mg/L-year would have strikingly highest risk of 10.3-fold and 15.7-fold, respectively, for the development carotid atherosclerosis, showing significant joint effect of arsenic exposure and risk genotypes of APOE and MCP-1. 18022660 2008
Entrez Id: 348
Gene Symbol: APOE
APOE
0.400 GeneticVariation disease BEFREE The association of the APO E epsilon4 allele with carotid atherosclerosis was significant in younger patients. 15809232 2005
Entrez Id: 348
Gene Symbol: APOE
APOE
0.400 GeneticVariation disease BEFREE Apolipoprotein E polymorphism and carotid atherosclerosis in patients with coronary disease. 15093983 2004
Entrez Id: 348
Gene Symbol: APOE
APOE
0.400 GeneticVariation disease BEFREE Association of APOE genotype with carotid atherosclerosis in men and women: the Framingham Heart Study. 15258198 2004
Entrez Id: 348
Gene Symbol: APOE
APOE
0.400 GeneticVariation disease BEFREE This cross-sectional study showed a synergistic effect between the intron 4 polymorphism or T(-786)-->C polymorphism of the eNOS gene and the apoE polymorphism with respect to risk for carotid atherosclerosis in nondiabetic hemodialysis patients. 12666069 2003
Entrez Id: 348
Gene Symbol: APOE
APOE
0.400 Biomarker disease BEFREE We investigated the distribution of four genetic polymorphisms (angiotensin converting enzyme [ACE], methylenetetrahydrofolate reductase [MTHFR], apolipoprotein E [apo E], and paraoxonase [PON] genes) in 30 subjects with VaSA, 30 subjects with moderate carotid atherosclerosis (ATS group), and 161 controls with a negative history for cardiovascular disease. 12196500 2002
Entrez Id: 348
Gene Symbol: APOE
APOE
0.400 GeneticVariation disease BEFREE Twenty-seven young (<50 years old) patients with spontaneous carotid artery dissection in 11 cases and carotid atherosclerosis in 16 cases were evaluated to determine the apolipoprotein E polymorphism. 11784371 2002
Entrez Id: 348
Gene Symbol: APOE
APOE
0.400 GeneticVariation disease BEFREE Our data suggested a synergistic effect between the apoE allele epsilon(4) and smoking on carotid atherosclerosis: odds ratios were 1.7 (95% CI, 0.8 to 3.6) for smoking alone, 1.0 (95% CI, 0.6 to 1.8) for epsilon4 alone, and 3.7 (95% CI, 1.1 to 3.6) for the joint presence of the apoE allele epsilon4 and smoking. 11988615 2002
Entrez Id: 348
Gene Symbol: APOE
APOE
0.400 GeneticVariation disease BEFREE Our data confirm the influence of apoE4 on cholesterol levels and clearly show that apoE genotype affects carotid atherosclerosis in its early stages in middle-aged asymptomatic subjects. 9012642 1997
Entrez Id: 6347
Gene Symbol: CCL2
CCL2
0.380 Biomarker disease BEFREE We evaluated the associations of 10 biomarkers of systemic inflammation (CRP, IL-6, sTNF-αR1 and 2), monocyte activation (CCL2, sCD163, sCD14), coagulation (fibrinogen, D-dimer), and endothelial dysfunction (ICAM-1) with subclinical carotid atherosclerosis among participants in the Multicenter AIDS Cohort Study (MACS). 30946765 2019
Entrez Id: 6347
Gene Symbol: CCL2
CCL2
0.380 GeneticVariation disease BEFREE The -928 guanine (G)/cytosine (C) and -362 G/C single-nucleotide polymorphisms (SNPs) in the proximal promoter region of the monocyte chemoattractant protein 1 gene have been associated with an increased risk for intimal medial thickness and carotid atherosclerosis, respectively. 20029197 2010
Entrez Id: 6347
Gene Symbol: CCL2
CCL2
0.380 GeneticVariation disease BEFREE The objective of this study was to evaluate the relation between the genotypes of the MCP-1 A-2518G polymorphism and the development of carotid atherosclerosis in patients with type 2 diabetes. 19781803 2009
Entrez Id: 6347
Gene Symbol: CCL2
CCL2
0.380 GeneticVariation disease BEFREE Single nucleotide polymorphisms in monocyte chemoattractant protein-1 and its receptor act synergistically to increase the risk of carotid atherosclerosis. 19506371 2009
Entrez Id: 6347
Gene Symbol: CCL2
CCL2
0.380 GeneticVariation disease BEFREE Additionally, study subjects with two risk genotypes of APOE and MCP-1 and either had ingested well water contained arsenic level >10 microg/L or had arsenic exposure >0.22 mg/L-year would have strikingly highest risk of 10.3-fold and 15.7-fold, respectively, for the development carotid atherosclerosis, showing significant joint effect of arsenic exposure and risk genotypes of APOE and MCP-1. 18022660 2008
Entrez Id: 6347
Gene Symbol: CCL2
CCL2
0.380 Biomarker disease CTD_human Additionally, study subjects with two risk genotypes of APOE and MCP-1 and either had ingested well water contained arsenic level >10 microg/L or had arsenic exposure >0.22 mg/L-year would have strikingly highest risk of 10.3-fold and 15.7-fold, respectively, for the development carotid atherosclerosis, showing significant joint effect of arsenic exposure and risk genotypes of APOE and MCP-1. 18022660 2008
Entrez Id: 6347
Gene Symbol: CCL2
CCL2
0.380 Biomarker disease BEFREE The influence of HIV infection on the correlation between plasma concentrations of monocyte chemoattractant protein-1 and carotid atherosclerosis. 16445900 2006
Entrez Id: 6347
Gene Symbol: CCL2
CCL2
0.380 GeneticVariation disease BEFREE None of the polymorphisms in CCL2 affected carotid atherosclerosis. 16799229 2006
Entrez Id: 6347
Gene Symbol: CCL2
CCL2
0.380 GeneticVariation disease BEFREE The purpose of this study was to clarify the association of the plasma level of MCP-1 and the SNP of the MCP-1 gene with carotid atherosclerosis in community-based subjects. 14620921 2003